Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories

Joshua A. Lieberman, Gregory Pepper, Samia N. Naccache, Meei-Li Huang, Keith R. Jerome, Alexander L. Greninger
doi: https://doi.org/10.1101/2020.04.24.20074559

Article Information

doi 
https://doi.org/10.1101/2020.04.24.20074559
History 
  • April 27, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Joshua A. Lieberman1,
  2. Gregory Pepper1,
  3. Samia N. Naccache2,
  4. Meei-Li Huang1,3,
  5. Keith R. Jerome1,3 and
  6. Alexander L. Greninger1,3,*
  1. 1Department of Laboratory Medicine, University of Washington Medical Center, Seattle, WA
  2. 2LabCorp Seattle, Department of Microbiology, Seattle, WA
  3. 3Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
  1. ↵* Corresponding author; email: gerbix{at}gmail.com
Back to top
Posted April 27, 2020.
Download PDF
Data/Code
Email
Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories
Joshua A. Lieberman, Gregory Pepper, Samia N. Naccache, Meei-Li Huang, Keith R. Jerome, Alexander L. Greninger
medRxiv 2020.04.24.20074559; doi: https://doi.org/10.1101/2020.04.24.20074559
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools

Subject Area